Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 17 Apr 2023

Clinical features and molecular genetics associated with brain metastasis in suspected early-stage non-small cell lung cancer

in Thoracic Oncology

Kangjoon Kim
Jibeom Lee
Jeong-Yun Lee
Seung Hyun Yong
Eun Young Kim
Ji Ye Jung
Young Ae Kang
Moo Suk Park
Young Sam Kim
Chang-Myung Oh

Frontiers in Oncology

doi 10.3389/fonc.2023.1148475

3,755 views
3 citations

Review

Published on 14 Apr 2023

The toxicity associated with combining immune check point inhibitors with tyrosine kinase inhibitors in patients with non-small cell lung cancer

in Thoracic Oncology

Anjali Kalra
Sawsan Rashdan

Frontiers in Oncology

doi 10.3389/fonc.2023.1158417

5,506 views
15 citations

Case Report

Published on 12 Apr 2023

Pulmonary blastoma treatment response to anti-PD-1 therapy: a rare case report and literature review

in Thoracic Oncology

Yalin Xie
Ning Su
Chaoxia Li
An Lei
Lei Li
Jianjun Zou
Wencang Cen
Jinxing Hu

Frontiers in Oncology

doi 10.3389/fonc.2023.1146204

2,889 views
7 citations

Original Research

Published on 12 Apr 2023

Efficacy and safety of pembrolizumab versus sintilimab treatment in patients with advanced squamous lung cancer: A real-world study in China

in Thoracic Oncology

Wenyu Yang
Tao Li
Yibing Bai
Yaping Long
Ming Gao
Ting Wang
Fangfang Jing
Fan Zhang
Haitao Tao
Junxun Ma

Frontiers in Oncology

doi 10.3389/fonc.2023.1147903

3,458 views
9 citations

Case Report

Published on 11 Apr 2023

Case report: anaplastic lymphoma kinase (ALK) rearranged adenocarcinoma with high level of microsatellite instability response to pembrolizumab

in Thoracic Oncology

Naoko Shigeta
Shuji Murakami
Tomoyuki Yokose
Yohei Miyagi
Haruhiro Saito

Frontiers in Oncology

doi 10.3389/fonc.2023.1110638

2,409 views
2 citations

Systematic Review

Published on 11 Apr 2023

Diagnostic value of combination of biomarkers for malignant pleural mesothelioma: a systematic review and meta-analysis

in Thoracic Oncology

Mucheng Zhu
Zhenhua Lu
Hao Guo
Xiaoting Gu
Defang Wei
Zhengyi Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1136049

2,763 views
2 citations

Case Report

Published on 11 Apr 2023

Primary ectopic meningioma in the thoracic cavity: A rare case report and review of the literature

in Thoracic Oncology

Xu Liu
Jiao Liu
Ting Nai
Yuxia Yang
Yuchang Hu

Frontiers in Oncology

doi 10.3389/fonc.2023.1149627

2,902 views
2 citations

Case Report

Published on 06 Apr 2023

Long-term survival with anlotinib as a front-line treatment in an elderly NSCLC patient: A case report

in Thoracic Oncology

Jingyi Wang
Xiaoqing Li
Juan Zhou
Dan Qiu
Mengyao Zhang
Lan Sun
Shengwen Calvin Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1043244

2,458 views
4 citations

Original Research

Published on 05 Apr 2023

Primary lung cancer in children and adolescents: Analysis of a surveillance, epidemiology, and end results database

in Thoracic Oncology

Weipeng Shao
Jie Liu
Bobo Li
Xiaokang Guo
Jian Sun
Hui Li
Hongbo Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1053248

11,259 views
16 citations

Original Research

Published on 05 Apr 2023

Reconsidering the T category for the T3 non-small cell lung cancer with additional tumor nodules in the same lobe: A population-based study

in Thoracic Oncology

Jing-Sheng Cai
Fan Yang
Xun Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1043386

2,683 views
9 citations

Clinical Trial

Published on 04 Apr 2023

Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancer

in Thoracic Oncology

Josephine Louella Feliciano
Dylan McLoone
Yingxin Xu
Ruben G.W. Quek
Andreas Kuznik
Jean-Francois Pouliot
Giuseppe Gullo
Petra Rietschel
Patricia Guyot
Gerasimos Konidaris

Frontiers in Oncology

doi 10.3389/fonc.2022.1081729

6,149 views
3 citations

Methods

Published on 04 Apr 2023

Is cancer stage data missing completely at random? A report from a large population-based cohort of non-small cell lung cancer

in Thoracic Oncology

Andrew G. Robinson
Paul Nguyen
Catherine L. Goldie
Matthew Jalink
Timothy P. Hanna

Frontiers in Oncology

doi 10.3389/fonc.2023.1146053

5,602 views
1 citation

Original Research

Published on 03 Apr 2023

Combined systemic immune-inflammatory index and prognostic nutritional index predict outcomes in advanced non-small cell lung cancer patients receiving platinum-doublet chemotherapy

in Thoracic Oncology

Ruiyun Fan
Ying Chen
Guopeng Xu
Wen Pan
Yantian Lv
Zhongwei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.996312

4,423 views
14 citations

Original Research

Published on 31 Mar 2023

Ultra-rapid Idylla™ EGFR mutation screening followed by next-generation sequencing: An integrated solution to molecular diagnosis of non-small cell lung cancer

in Thoracic Oncology

Tian Qiu
Fanshuang Zhang
Bo Zheng
Zitong Feng
Weihua Li
Hua Zeng
Lixia Chu
Jianming Ying

Frontiers in Oncology

doi 10.3389/fonc.2023.1064487

3,944 views
2 citations

Case Report

Published on 31 Mar 2023

Case report: Primary pleural giant extraskeletal Ewing sarcoma in a child

in Thoracic Oncology

Yang Wu
Chao-Bang Xie
Qiong Huang
Kai-Fei Zhao

Frontiers in Oncology

doi 10.3389/fonc.2023.1137586

2,771 views
6 citations

Original Research

Published on 30 Mar 2023

Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center study

in Thoracic Oncology

Kailun Fei
Gang Guo
Jie Wang
Zhijie Wang
Yan Wang
Xuezhi Hao
Jia Zhong
Qinxiang Guo
Wei Guo
Wenzhong Su

Frontiers in Oncology

doi 10.3389/fonc.2023.1145303

3,324 views
4 citations

Original Research

Published on 28 Mar 2023

Surgical selection and regional lymph node dissection for stage I second primary lung cancer patients following surgery for stage I first primary lung cancer

in Thoracic Oncology

Xiao Wu
Youhua Jiang
Qixun Chen
Jiangfeng Wang
Jianqiang Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1148422

1,593 views
1 citation

Original Research

Published on 27 Mar 2023

Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset

in Thoracic Oncology

Kumar Prabhash
Daniel Shao Weng Tan
Ross A. Soo
Piyada Sitthideatphaiboon
Yuh Min Chen
Pei Jye Voon
Elisna Syahruddin
Sojung Chu
Reto Huggenberger
Byoung-Chul Cho

Frontiers in Oncology

doi 10.3389/fonc.2023.1117348

6,592 views
7 citations

Original Research

Published on 27 Mar 2023

Clinical features and prognosis of pulmonary enteric adenocarcinoma: A retrospective study in China and the SEER database

in Thoracic Oncology

Qike Wang
Lu Zhang
Huahua Li
Linlin Liu
Xu Sun
Huaimin Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1099117

3,485 views
10 citations

Case Report

Published on 24 Mar 2023

Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer

in Thoracic Oncology

Pamela Soberanis Pina
Luis Lara-Mejía
Venecia Matias-Cruz
Feliciano Barrón
Andrés F. Cardona
Luis E. Raez
Eduardo Rios-Garcia
Oscar Arrieta

Frontiers in Oncology

doi 10.3389/fonc.2023.1108124

4,790 views
10 citations

Original Research

Published on 24 Mar 2023

Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging

in Thoracic Oncology

Saud Alhusaini
Tyler A. Lanman
Ryan B. Ko
Kate E. Therkelsen
Rie Von Eyben
Maximilian Diehn
Scott G. Soltys
Erqi L. Pollom
Alexander Chin
Lucas Vitzthum

Frontiers in Oncology

doi 10.3389/fonc.2023.1139940

3,798 views
1 citation

Original Research

Published on 23 Mar 2023

A study of the prognosis of patients with limited-stage small cell lung cancer who did or did not receive prophylactic cranial irradiation after effective chemoradiotherapy

in Thoracic Oncology

Qing Wu
Mengyuan Chen
Fang Peng
Qun Zhang
Yue Kong
Yong Bao
Yujin Xu
Xiao Hu
Ming Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1118371

2,865 views
10 citations

Original Research

Published on 23 Mar 2023

Immunotherapy combined with rh-endostatin improved clinical outcomes over immunotherapy plus chemotherapy for second-line treatment of advanced NSCLC

in Thoracic Oncology

Hongxiang Huang
Peiyuan Zhong
Xie Zhu
Silv Fu
Siling Li
Sujuan Peng
Yangyang Liu
Zhihui Lu
Li Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1137224

2,585 views
14 citations

Original Research

Published on 23 Mar 2023

Neoadjuvant radiotherapy plus single-incision thoracoscopic surgery in the treatment of type B3 thymomas

in Thoracic Oncology

Wenshan Li
Yimin Wu
Lijian Huang
Ying Chai

Frontiers in Oncology

doi 10.3389/fonc.2023.1094974

1,984 views

1,929 articles

articles

Clinical features and molecular genetics associated with brain metastasis in suspected early-stage non-small cell lung cancer

The toxicity associated with combining immune check point inhibitors with tyrosine kinase inhibitors in patients with non-small cell lung cancer

Pulmonary blastoma treatment response to anti-PD-1 therapy: a rare case report and literature review

Efficacy and safety of pembrolizumab versus sintilimab treatment in patients with advanced squamous lung cancer: A real-world study in China

Case report: anaplastic lymphoma kinase (ALK) rearranged adenocarcinoma with high level of microsatellite instability response to pembrolizumab

Diagnostic value of combination of biomarkers for malignant pleural mesothelioma: a systematic review and meta-analysis

Primary ectopic meningioma in the thoracic cavity: A rare case report and review of the literature

Long-term survival with anlotinib as a front-line treatment in an elderly NSCLC patient: A case report

Primary lung cancer in children and adolescents: Analysis of a surveillance, epidemiology, and end results database

Reconsidering the T category for the T3 non-small cell lung cancer with additional tumor nodules in the same lobe: A population-based study

Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancer

Is cancer stage data missing completely at random? A report from a large population-based cohort of non-small cell lung cancer

Combined systemic immune-inflammatory index and prognostic nutritional index predict outcomes in advanced non-small cell lung cancer patients receiving platinum-doublet chemotherapy

Ultra-rapid Idylla™ EGFR mutation screening followed by next-generation sequencing: An integrated solution to molecular diagnosis of non-small cell lung cancer

Case report: Primary pleural giant extraskeletal Ewing sarcoma in a child

Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center study

Surgical selection and regional lymph node dissection for stage I second primary lung cancer patients following surgery for stage I first primary lung cancer

Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset

Clinical features and prognosis of pulmonary enteric adenocarcinoma: A retrospective study in China and the SEER database

Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer

Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging

A study of the prognosis of patients with limited-stage small cell lung cancer who did or did not receive prophylactic cranial irradiation after effective chemoradiotherapy

Immunotherapy combined with rh-endostatin improved clinical outcomes over immunotherapy plus chemotherapy for second-line treatment of advanced NSCLC

Neoadjuvant radiotherapy plus single-incision thoracoscopic surgery in the treatment of type B3 thymomas